Latest Breaking News On - Slovenian pharmaceutical company lek started the construction ofa 400 million euro 432 biosimilars production plant in lendava - Page 1 : comparemela.com
Slovenian pharmaceutical company Lek started the construction of a 400 million euro ($432 million) biosimilars production plant in Lendava, the government said.